MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Use with caution

Adizem-XL 180mg capsules (Napp Pharmaceuticals Ltd)

Explore other Diltiazem formulations Explore other Diltiazem 180mg modified-release capsules suppliers

Stability Notes

Should be stored in airtight, light-resistant containers. Excessive humidity should be avoided.

Provenance

This compatibility recommendation is derived from Adizem-SR and XL 180mg capsules (Napp Pharmaceuticals Ltd), Angitil SR 180 capsules (Ethypharm UK Ltd), Viazem XL 180mg capsules (Thornton & Ross Ltd) and Zemtard 180 XL capsules (Galen Ltd).

Use with caution

Adizem-XL 200mg capsules (Lexon (UK) Ltd)

Explore other Diltiazem formulations Explore other Diltiazem 200mg modified-release capsules suppliers

Stability Notes

Store in an airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tildiem LA 200 capsules (Sanofi).

Use with caution

Adizem-XL 200mg capsules (Napp Pharmaceuticals Ltd)

Explore other Diltiazem formulations Explore other Diltiazem 200mg modified-release capsules suppliers

Stability Notes

Store in an airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tildiem LA 200 capsules (Sanofi).

Use with caution

Adizem-XL 240mg capsules (Lexon (UK) Ltd)

Explore other Diltiazem formulations Explore other Diltiazem 240mg modified-release capsules suppliers

Stability Notes

Should be stored in airtight, light-resistant containers. Excessive humidity should be avoided.

Provenance

This compatibility recommendation is derived from Adizem-XL 240mg capsules (Napp Pharmaceuticals Ltd), Angitil XL 240 capsules (Ethypharm UK Ltd), Viazem XL 240mg capsules (Thornton & Ross Ltd) and Zemtard 240 XL capsules (Galen Ltd).

Use with caution

Adizem-XL 240mg capsules (Napp Pharmaceuticals Ltd)

Explore other Diltiazem formulations Explore other Diltiazem 240mg modified-release capsules suppliers

Stability Notes

Should be stored in airtight, light-resistant containers. Excessive humidity should be avoided.

Provenance

This compatibility recommendation is derived from Adizem-XL 240mg capsules (Napp Pharmaceuticals Ltd), Angitil XL 240 capsules (Ethypharm UK Ltd), Viazem XL 240mg capsules (Thornton & Ross Ltd) and Zemtard 240 XL capsules (Galen Ltd).

Use with caution

Adizem-XL 300mg capsules (Lexon (UK) Ltd)

Explore other Diltiazem formulations Explore other Diltiazem 300mg modified-release capsules suppliers

Stability Notes

Should be stored in airtight, light-resistant containers. Excessive humidity should be avoided.

Provenance

This compatibility recommendation is derived from Adizem-XL 300mg capsules (Napp Pharmaceuticals Ltd), Angitil XL 300 capsules (Ethypharm UK Ltd), Tildiem LA 300, Viazem XL 300mg capsules (Thornton & Ross Ltd) and Zemtard 300 XL capsules (Galen Ltd).

Use with caution

Adizem-XL 300mg capsules (Napp Pharmaceuticals Ltd)

Explore other Diltiazem formulations Explore other Diltiazem 300mg modified-release capsules suppliers

Stability Notes

Should be stored in airtight, light-resistant containers. Excessive humidity should be avoided.

Provenance

This compatibility recommendation is derived from Adizem-XL 300mg capsules (Napp Pharmaceuticals Ltd), Angitil XL 300 capsules (Ethypharm UK Ltd), Tildiem LA 300, Viazem XL 300mg capsules (Thornton & Ross Ltd) and Zemtard 300 XL capsules (Galen Ltd).

No Stability Information

AdMag 100mg tablets (Essential-Healthcare Ltd)

Explore other Magnesium oxide formulations Explore other Magnesium oxide 100mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

AdMag 160mg tablets (Essential-Healthcare Ltd)

Explore other Magnesium oxide formulations Explore other Magnesium oxide 160mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

AdMag 400mg tablets (Essential-Healthcare Ltd)

Explore other Magnesium oxide formulations Explore other Magnesium oxide 400mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

AdMag heavy 500mg capsules (Essential-Healthcare Ltd)

Explore other Magnesium carbonate formulations Explore other Magnesium carbonate heavy 500mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

Incompatible

Adoport 0.5mg capsules (Sandoz Ltd)

Explore other Tacrolimus formulations Explore other Tacrolimus 500microgram capsules suppliers

Stability Notes

Unsuitable for MCA. Keep in the original package to protect from light and moisture.

Incompatible

Adoport 0.75mg capsules (Sandoz Ltd)

Explore other Tacrolimus formulations Explore other Tacrolimus 750microgram capsules suppliers

Stability Notes

Unsuitable for MCA. Keep in the original package to protect from light and moisture.

Incompatible

Adoport 1mg capsules (Sandoz Ltd)

Explore other Tacrolimus formulations Explore other Tacrolimus 1mg capsules suppliers

Stability Notes

Unsuitable for MCA. Keep in the original package to protect from light and moisture.

Incompatible

Adoport 2mg capsules (Sandoz Ltd)

Explore other Tacrolimus formulations Explore other Tacrolimus 2mg capsules suppliers

Stability Notes

Unsuitable for MCA. Keep in the original package to protect from light and moisture.

Print this list

Compatible

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Use with caution

There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Incompatible

Medicines under this category are not suitable for use in MCAs.

No Stability Information

These medicines have not been reviewed by SPS.